Effects of ataxia telangiectasia mutated (ATM) genotypes and smoking habits on lung cancer risk in Taiwan

Anticancer Research

Volumn 33, Issue 9, 2013, Pages 4067-4072

  Hsia, Te Chun ^a,b   Tsai, Chia Wen ^a,b   Liang, Shinn Jye ^a   Chang, Wen Shin ^a,b   Lin, Liang Yi ^a   Chen, Wei Chun ^a,b   Tu, Chih Yen ^a   Tsai, Chang Hai ^a   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ATM; Genotype; Lung cancer; Polymorphism; Smoking

Indexed keywords

ATM PROTEIN;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LIFESTYLE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TAIWAN;

ATM; GENOTYPE; LUNG CANCER; POLYMORPHISM; SMOKING;

AGED; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIFE STYLE; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; TAIWAN;

EID: 84885006184     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Hecht SS: Cigarette smoking and lung cancer: Chemical mechanisms and approaches to prevention. Lancet Oncol 3: 461-469, 2002.
3. Shields PG: Molecular epidemiology of smoking and lung cancer. Oncogene 21: 6870-6876, 2002.
4. Shields PG and Harris CC: Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18: 2309-2315, 2000.
5. Spitz MR, Wei Q, Dong Q, Amos CI and Wu X: Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 12: 689-698, 2003.
6. Hsia TC, Liu CJ, Chu CC, Hang LW, Chang WS, Tsai CW, Wu CI, Lien CS, Liao WL, Ho CY and Bau DT: Association of DNA double-strand break gene XRCC6 genotypes and lung cancer in Taiwan. Anticancer Res 32: 1015-1020, 2012.
7. Tsai CW, Tsai MH, Tsou YA, Shih LC, Tseng HC, Chang WS, Ho CY, Lee HZ and Bau DT: The joint effect of smoking and hOGG1 genotype on oral cancer in Taiwan. Anticancer Res 32: 3799-3803, 2012.
8. Hsia TC, Liu CJ, Lin CH, Chang WS, Chu CC, Hang LW, Lee HZ, Lo WC and Bau DT: Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients. Anticancer Res 31: 3601-3605, 2011.
9. Bau DT, Yang MD, Tsou YA, Lin SS, Wu CN, Hsieh HH, Wang RF, Tsai CW, Chang WS, Hsieh HM, Sun SS and Tsai RY: Colorectal cancer and genetic polymorphism of DNA doublestrand break repair gene XRCC4 in Taiwan. Anticancer Res 30: 2727-2730, 2010.
10. Liu CJ, Hsia TC, Tsai RY, Sun SS, Wang CH, Lin CC, Tsai CW, Huang CY, Hsu CM and Bau DT: The joint effect of hOGG1 single nucleotide polymorphism and smoking habit on lung cancer in Taiwan. Anticancer Res 30: 4141-4145, 2010.
11. Abraham RT: PI-3-kinase related kinases: 'big' players in stress-induced signaling pathways. DNA Repair 3: 883-887, 2004.
12. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y and Ziv Y: Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674-1677, 1998.
13. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB and Siliciano JD: Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677-1679, 1998.
14. Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y, Kastan MB, Katzir E and Oren M: ATM-dependent phosphorylation of MDM2 on serine 395: Role in p53 activation by DNA damage. Genes Dev 15: 1067-1077, 2001.
15. Bartek J, Falck J and Lukas J: CHK2 kinase-a busy messenger. Nat Rev Mol Cell Biol 2: 877-886, 2001.
16. Timme TL, Goltsov A, Tahir S, Li L, Wang J, Ren C, Johnston RN and Thompson TC: Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis. Oncogene 19: 3256-3265, 2000.
17. Lim DS, Kim ST, Xu B, Maser RS, Lin J, Petrini JH and Kastan MB: ATM phosphorylates p95/NBS1 in an S-phase checkpoint pathway. Nature 404: 613-617, 2000.
18. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR and Rahman N: ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38: 873-875, 2006.
19. Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M and Easton DF: Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97: 813-822, 2005.
20. Wang HC, Chang WS, Tsai RY, Tsai CW, Liu LC, Su CH, Cheng HN, Tsou YA, Sun SS, Lin CC and Bau DT: Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females. Anticancer Res 30: 5217-5221, 2010.
21. Shen L, Yin ZH, Wan Y, Zhang Y, Li K and Zhou BS: Association between ATM polymorphisms and cancer risk: a meta-analysis. Mol Biol Rep 39: 5719-5725, 2012.
22. Bau DT, Chang CH, Tsai MH, Chiu CF, Tsou YA, Wang RF, Tsai CW and Tsai RY: Association between DNA repair gene, ATM polymorphisms and oral cancer susceptibility. Laryngoscope 120: 2417-2422, 2010.
23. Kim JH, Kim H, Lee KY, Choe KH, Ryu JS, Yoon HI, Sung SW, Yoo KY and Hong YC: Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk. Hum Mol Genet 15: 1181-1186, 2006.
24. Hall J, Marcel V, Bolin C, Fernet M, Tartier L, Vaslin L and Hainaut P: The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: Genotype-phenotype correlations. Biochem Soc Trans 37: 527-533, 2009.
25. Yang H, Spitz MR, Stewart DJ, Lu C, Gorlov IP and Wu X: ATM sequence variants associate with susceptibility to non-small cell lung cancer. Int J Cancer 121: 2254-2259, 2007.
26. Lo YL, Hsiao CF, Jou YS, Chang GC, Tsai YH, Su WC, Chen YM, Huang MS, Chen HL, Yang PC, Chen CJ and Hsiung CA: ATM polymorphisms and risk of lung cancer among never smokers. Lung Cancer 69: 148-154, 2010.
27. Deng Q, Sheng L, Su D, Zhang L, Liu P, Lu K and Ma S: Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China. Med Oncol 28: 667-672, 2011.
28. Dong J, Hu Z, Shu Y, Pan S, Chen W, Wang Y, Hu L, Jiang Y, Dai J, Ma H, Jin G and Shen H: Potentially functional polymorphisms in DNA repair genes and non-small cell lung cancer survival: A pathway-based analysis. Mol Carcinog 51: 546-552, 2012.
29. Schneider J, Illig T, Rosenberger A, Bickeboller H and Wichmann HE: Detection of ATM gene mutations in young lung cancer patients: A population-based control study. Arch Med Res 39: 226-231, 2008.
30. Barrett JC, Fry B, Maller J and Daly MJ: Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265, 2005.
31. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS and Shiloh Y: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753, 1995.
32. Dombernowsky SL, Weischer M, Allin KH, Bojesen SE, Tybjaerg-Hansen A and Nordestgaard BG: Risk of cancer by ATM missense mutations in the general population. J Clin Oncol 26: 3057-3062, 2008.
33. Shiloh Y and Kastan MB: ATM: genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 83: 209-254, 2001.
34. Broeks A, Urbanus JH, Floore AN, Dahler EC, Klijn JG, Rutgers EJ, Devilee P, Russell NS, van Leeuwen FE and van't Veer LJ: ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet 66: 494-500, 2000.